Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions View by Topic View by Date Must Reads In Pediatrics Pediatrics for November/December 2019 ADA2 is a potent new biomarker for macrophage activation syndrome, Tofacitinib Improves Disease Activity in Patients With Polyarticular-Course JIA, AAD-NPF Pediatric Psoriasis Guideline Advises on Physical and Mental Care, Psoriasis Risk Rises With TNF Inhibitor Use in Children With Inflammatory Disorders, Marked Increase in Psoriasis Seen With TNFi Use in Pediatric Inflammatory Diseases, More must reads Pediatrics for September/October 2019 PASI-75 With Ixekizumab Approaches 90% in Pediatric Psoriasis Study, Anakinra Treatment for Pediatric ‘Cytokine Storms’, Juvenile Dermatomyositis Derails Growth and Pubertal Development, Bisphosphonates Improve BMD in Pediatric Rheumatic Disease, More must readsPediatrics for July/August 2019 Emapalumab Produces Major Responses in Macrophage Activation Syndrome, Mechanism Does Not Matter for Second-Line Biologic Choice in JIA, Tocilizumab Associated With Improved Vision in Some JIA patients , More must readsPediatrics for May/June 2019 Booster Vaccines Safe in Children on Immunosuppressive Drugs, Efforts toward producing CNO/CRMO classification criteria show first results, Various adjuncts to IVIg help treat coronary artery abnormalities in pediatric Kawasaki disease, More must readsPediatrics for March/April 2019 Childhood-Onset SLE Rate Higher in Children Born in Winter, More must readsPages« first 1 2 3 last »
